메뉴 건너뛰기




Volumn 19, Issue 11, 2013, Pages 1534-1536

Proceedings from the National Cancer Institute's second international workshop on the biology, prevention, and treatment of relapse after hematopoietic stem cell transplantation: Introduction

Author keywords

Allogeneic; Autologous; Hematologic malignancies; Hematopoietic stem cell transplantation; Post transplant relapse

Indexed keywords

ALLOGRAFT; ARTICLE; CANCER CELL; CANCER PREVENTION; CANCER RECURRENCE; CAUSE OF DEATH; CLINICAL RESEARCH; DONOR LYMPHOCYTE INFUSION; EARLY INTERVENTION; EVENT FREE SURVIVAL; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MINIMAL RESIDUAL DISEASE; MULTIPLE MYELOMA; NATIONAL HEALTH ORGANIZATION; NATURAL KILLER CELL; PROGRESSION FREE SURVIVAL;

EID: 84885822653     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2013.08.016     Document Type: Article
Times cited : (26)

References (17)
  • 1
    • 84885778326 scopus 로고    scopus 로고
    • Current use and outcome of hematopoietic stem cell transplantation: CIBMTR Summary Slides, 2012. Available at:
    • Pasquini MC, Wang Z. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR Summary Slides, 2012. Available at: http://www.cibmtr.org.
    • Pasquini, M.C.1    Wang, Z.2
  • 2
    • 77951588418 scopus 로고    scopus 로고
    • Introduction to the reports from the National Cancer Institute First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
    • Bishop M.R., Alyea E.P., Cairo M.S., et al. Introduction to the reports from the National Cancer Institute First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 2010, 16:563-564.
    • (2010) Biol Blood Marrow Transplant , vol.16 , pp. 563-564
    • Bishop, M.R.1    Alyea, E.P.2    Cairo, M.S.3
  • 3
    • 77952580739 scopus 로고    scopus 로고
    • NCI first International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Report from the Committee on the Biological Considerations of Hematological Relapse Following Allogeneic Stem Cell Transplantation Unrelated to Graft-Versus-Tumor Effects: state of the science
    • Cairo M.S., Jordan C.T., Maley C.C., et al. NCI first International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Report from the Committee on the Biological Considerations of Hematological Relapse Following Allogeneic Stem Cell Transplantation Unrelated to Graft-Versus-Tumor Effects: state of the science. Biol Blood Marrow Transplant 2010, 16:709-728.
    • (2010) Biol Blood Marrow Transplant , vol.16 , pp. 709-728
    • Cairo, M.S.1    Jordan, C.T.2    Maley, C.C.3
  • 4
    • 77953587073 scopus 로고    scopus 로고
    • NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell Transplantation
    • Pavletic S.Z., Kumar S., Mohty M., et al. NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell Transplantation. Biol Blood Marrow Transplant 2010, 16:871-890.
    • (2010) Biol Blood Marrow Transplant , vol.16 , pp. 871-890
    • Pavletic, S.Z.1    Kumar, S.2    Mohty, M.3
  • 5
    • 77951149575 scopus 로고    scopus 로고
    • NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-tumor/leukemia reaction
    • Miller J.S., Warren E.H., van den Brink M.R., et al. NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-tumor/leukemia reaction. Biol Blood Marrow Transplant 2010, 16:565-586.
    • (2010) Biol Blood Marrow Transplant , vol.16 , pp. 565-586
    • Miller, J.S.1    Warren, E.H.2    van den Brink, M.R.3
  • 6
    • 77954288771 scopus 로고    scopus 로고
    • NCI First International Workshop on the Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the Committee on Prevention of Relapse following Allogeneic Cell Transplantation for Hematologic Malignancies
    • Alyea E.P., DeAngelo D.J., Moldrem J., et al. NCI First International Workshop on the Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the Committee on Prevention of Relapse following Allogeneic Cell Transplantation for Hematologic Malignancies. Biol Blood Marrow Transplant 2010, 16:1037-1069.
    • (2010) Biol Blood Marrow Transplant , vol.16 , pp. 1037-1069
    • Alyea, E.P.1    DeAngelo, D.J.2    Moldrem, J.3
  • 7
    • 77955503223 scopus 로고    scopus 로고
    • NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation, Report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation, part I: methods, acute leukemias, and myelodysplastic syndromes
    • Erratum 16:1752
    • Kröger N., Bacher U., Bader P., et al. NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation, Report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation, part I: methods, acute leukemias, and myelodysplastic syndromes. Biol Blood Marrow Transplant 2010, 16:1187-1211. Erratum 16:1752.
    • (2010) Biol Blood Marrow Transplant , vol.16 , pp. 1187-1211
    • Kröger, N.1    Bacher, U.2    Bader, P.3
  • 8
    • 77956309607 scopus 로고    scopus 로고
    • NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation, part II: chronic leukemias, myeloproliferative neoplasms, and lymphoid malignancies
    • Kröger N., Bacher U., Bader P., et al. NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation, part II: chronic leukemias, myeloproliferative neoplasms, and lymphoid malignancies. Biol Blood Marrow Transplant 2010, 16:1325-1346.
    • (2010) Biol Blood Marrow Transplant , vol.16 , pp. 1325-1346
    • Kröger, N.1    Bacher, U.2    Bader, P.3
  • 9
    • 77957754106 scopus 로고    scopus 로고
    • NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
    • Porter D.L., Alyea E.P., Antin J.H., et al. NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 2010, 16:1467-1503.
    • (2010) Biol Blood Marrow Transplant , vol.16 , pp. 1467-1503
    • Porter, D.L.1    Alyea, E.P.2    Antin, J.H.3
  • 10
    • 79952609273 scopus 로고    scopus 로고
    • National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committee
    • Bishop M.R., Alyea E.P., Cairo M.S., et al. National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committee. Biol Blood Marrow Transplant 2011, 17:443-454.
    • (2011) Biol Blood Marrow Transplant , vol.17 , pp. 443-454
    • Bishop, M.R.1    Alyea, E.P.2    Cairo, M.S.3
  • 11
    • 84863337617 scopus 로고    scopus 로고
    • Clonal architecture of secondary acute myeloid leukemia
    • Walter M.J., Shen D., Ding L., et al. Clonal architecture of secondary acute myeloid leukemia. NEngl J Med 2012, 366:1090-1098.
    • (2012) NEngl J Med , vol.366 , pp. 1090-1098
    • Walter, M.J.1    Shen, D.2    Ding, L.3
  • 12
    • 84862776906 scopus 로고    scopus 로고
    • Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
    • Ding L., Ley T.J., Larson D.E., et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 2012, 481:506-510.
    • (2012) Nature , vol.481 , pp. 506-510
    • Ding, L.1    Ley, T.J.2    Larson, D.E.3
  • 13
    • 84860709392 scopus 로고    scopus 로고
    • Lenalidomide maintenance after stem-cell transplantation for multiple myeloma
    • IFM Investigators
    • Attal M., Lauwers-Cances V., Marit G., et al. Lenalidomide maintenance after stem-cell transplantation for multiple myeloma. NEngl J Med 2012, 366:1782-1791. IFM Investigators.
    • (2012) NEngl J Med , vol.366 , pp. 1782-1791
    • Attal, M.1    Lauwers-Cances, V.2    Marit, G.3
  • 14
    • 84860741191 scopus 로고    scopus 로고
    • Lenalidomide after stem-cell transplantation for multiple myeloma
    • McCarthy P.L., Owzar K., Hofmeister C.C., et al. Lenalidomide after stem-cell transplantation for multiple myeloma. NEngl J Med 2012, 366:1770-1781.
    • (2012) NEngl J Med , vol.366 , pp. 1770-1781
    • McCarthy, P.L.1    Owzar, K.2    Hofmeister, C.C.3
  • 15
    • 78649601394 scopus 로고    scopus 로고
    • Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: a dose- and schedule-finding study
    • de Lima M., Giralt S., Thall P.F., et al. Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: a dose- and schedule-finding study. Cancer 2010, 116:5420-5431.
    • (2010) Cancer , vol.116 , pp. 5420-5431
    • de Lima, M.1    Giralt, S.2    Thall, P.F.3
  • 16
    • 84878945027 scopus 로고    scopus 로고
    • Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation
    • Schroeder T., Czibere A., Platzbecker U., et al. Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation. Leukemia 2013, 27:1229-1235.
    • (2013) Leukemia , vol.27 , pp. 1229-1235
    • Schroeder, T.1    Czibere, A.2    Platzbecker, U.3
  • 17
    • 78651290248 scopus 로고    scopus 로고
    • Complete remission after blinatumomab-induced donor T-cell activation in three pediatric patients with post-transplant relapsed acute lymphoblastic leukemia
    • Handgretinger R., Zugmaier G., Henze G., et al. Complete remission after blinatumomab-induced donor T-cell activation in three pediatric patients with post-transplant relapsed acute lymphoblastic leukemia. Leukemia 2011, 25:181-184.
    • (2011) Leukemia , vol.25 , pp. 181-184
    • Handgretinger, R.1    Zugmaier, G.2    Henze, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.